Michael F. Mahoney - 16 Feb 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
Chairman, President & CEO, Director
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
16 Feb 2023
Net transactions value
-$1,050,347
Form type
4
Filing time
21 Feb 2023, 15:19:22 UTC
Previous filing
16 Feb 2023
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +16,264 +0.9% $0.000000 1,829,415 16 Feb 2023 Direct F1
transaction BSX Common Stock Tax liability $335,307 -7,214 -0.39% $46.48 1,822,201 16 Feb 2023 Direct
transaction BSX Common Stock Options Exercise $0 +18,333 +1% $0.000000 1,840,534 17 Feb 2023 Direct F1
transaction BSX Common Stock Tax liability $378,417 -8,131 -0.44% $46.54 1,832,403 17 Feb 2023 Direct
transaction BSX Common Stock Options Exercise $0 +16,307 +0.89% $0.000000 1,848,710 18 Feb 2023 Direct F2
transaction BSX Common Stock Tax liability $336,624 -7,233 -0.39% $46.54 1,841,477 18 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -16,264 -25% $0.000000 48,795 16 Feb 2023 Common Stock 16,264 Direct F1, F3
transaction BSX Restricted Stock Units Options Exercise $0 -18,333 -33% $0.000000 36,667 17 Feb 2023 Common Stock 18,333 Direct F1, F4
transaction BSX Deferred Stock Units Options Exercise $0 -16,307 -50% $0.000000 16,307 18 Feb 2023 Common Stock 16,307 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F5 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.